康希诺：吸入用肺结核疫苗于印尼启动Ⅰ期临床试验并完成首例受试者入组

Core Viewpoint - The company announced the initiation of Phase I clinical trials for its inhaled tuberculosis vaccine in Indonesia, marking a significant step in its development process [1] Group 1 - The inhaled tuberculosis vaccine is based on a type 5 adenoviral vector [1] - The first subject has been enrolled in the Phase I clinical trial [1]